HENRY CHRISTIAN O 4

4 · PACIFIC BIOSCIENCES OF CALIFORNIA, INC. · Filed Mar 3, 2026

AI-generated summary of this filing

Updated Mar 3, 2026

Pacific Biosciences (PACB) CEO Christian Henry Receives Awards

What Happened

Christian Henry, President & CEO of Pacific Biosciences (PACB), received equity awards on 2026-02-27: 920,810 restricted stock units (RSUs) and a derivative award covering 1,841,621 shares (both granted at $0.00). No cash was exchanged — these are compensation awards rather than open‑market purchases or sales.

Key Details

Transaction date: 2026-02-27; Form 4 filed 2026-03-03 (timely within required filing window).
Awards granted: 920,810 RSUs @ $0.00; 1,841,621 derivative/option-format shares @ $0.00 — total 2,762,431 shares granted.
Vesting: RSUs vest in equal annual installments on Feb 15 of 2027, 2028 and 2029 (F1). The derivative/option award vests in 36 equal monthly installments beginning March 27, 2026 (F2).
Shares owned after the transaction: not disclosed in the filing.
Filing status: reported on a Form 4 and appears timely (filed within two business days after the grant date).

Context

RSUs are a promise to deliver shares if vesting/service conditions are met; the option-like award vests monthly over three years. Neither award involved an immediate exercise or sale of shares — they are forward-looking compensation. Such grants are common for executives and reflect compensation structure rather than direct insider buying or selling activity.

Form 4

Period: 2026-02-27

See Remarks

Transactions

Award
Common Stock
[F1]
2026-02-27+920,810→ 3,594,310 total
Award
Stock Option (right to buy)
[F2]
2026-02-27+1,841,621→ 1,841,621 total
Exercise: $1.68Exp: 2036-02-27→ Common Stock (1,841,621 underlying)

Footnotes (2)

[F1]Each share is represented by a Restricted Stock Unit ("RSU"). The RSUs will vest in equal annual installments on February 15 of each of 2027, 2028, and 2029, subject to the Reporting Person's continued status as a service provider through the applicable vesting dates.
[F2]The shares subject to the option will vest in 36 equal monthly installments beginning on March 27, 2026, subject to the Reporting Person's continued status as a service provider through the applicable vesting dates.

Signature

/s/ Michele Farmer, Attorney-in-fact|2026-03-03

1 file